Aspivix | 7,021 followers on LinkedIn. Together, Re-imagining Gynecology with "Gentle" in Mind. | Aspivix is a medical device company in women’s health, based in Switzerland and in California, developing next-generation devices for gynecology. Our flagship product, carevix®, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. Recognized as one the Best Inventions 2024 by TIME, carevix® is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. carevix® study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the pain by up to 73% and the bleeding by up to 83% in IUD insertions.